| Oct 23 |
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) and HOPE Therapeutics, Inc. Announce Participation at the ThinkEquity Conference October 30, 2024
|
| Oct 21 |
NRx started at buy by EF Hutton, cites suicide prevention focus
|
| Oct 12 |
NRx Pharmaceuticals Leadership Shift and Strategic Governance Decisions
|
| Oct 3 |
HOPE Therapeutics and NRx Pharmaceuticals acquires a West Coast psychiatric clinic
|
| Oct 3 |
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire a Premier West Coast Interventional Psychiatric Clinic
|
| Sep 30 |
NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announces Completion of Twelve Months of Stability on the First Manufactured Commercial Scale Lot of NRX-100 (Ketamine)
|
| Sep 11 |
NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Featured on Psychiatrist.com
|
| Aug 26 |
HOPE Therapeutics Secures Financing For Ketamine Clinic Expansion
|
| Aug 15 |
NRx Pharmaceuticals, Inc. (NRXP) Q2 2024 Earnings Call Transcript
|
| Aug 14 |
NRx Pharmaceuticals (NASDAQ:NRXP) Reports Second Quarter and Year to Date 2024 Financial Results and Provides Business Update
|
